Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone

作者: Yasmin Ohana Haim , Naamit Deshet Unger , Miriam C. Souroujon , Moshe Mittelman , Drorit Neumann

DOI: 10.1038/SREP04323

关键词:

摘要: Glucocorticoids (GC) display pleiotropic effects on the immune system. Macrophages are a major target for GC action. Here we show that dexamethasone (DEX), synthetic GC, decreased viability of naive bone marrow-derived macrophages (BMDM), involving an apoptotic mechanism. Administration DEX together with lipopolysaccharide (LPS) protected BMDM against DEX-mediated cell death, suggesting activated respond to differently than BMDM. An insight molecular basis LPS actions was provided by 7 fold increase in mRNA levels glucocorticoid receptor beta (GRβ), GR dominant-negative splice variant which inhibits GRα's transcriptional activity. did not inhibit all BMDM; significantly reduced percentage expressing high surface markers F4/80 and CD11b led decrease macrophage inflammatory protein 1 alpha (MIP1-α) levels. These two were prevented LPS. Our finding reduce DEX-induced elevation glucocorticoid-induced leucine zipper (GILZ), mediator GCs anti-inflammatory actions, may provide underlying findings enable better understanding clinical states, such as sepsis, endotoxins treatment is considered.

参考文章(47)
Andrea Classen, Jorge Lloberas, Antonio Celada, Macrophage activation: classical versus alternative. Methods of Molecular Biology. ,vol. 531, pp. 29- 43 ,(2009) , 10.1007/978-1-59745-396-7_3
Yen-Shen Lu, Huang-Chun Lien, Pei-Yen Yeh, Kun-Huei Yeh, Min-Liang Kuo, Sung-Hsin Kuo, Ann-Lii Cheng, Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors World Journal of Gastroenterology. ,vol. 11, pp. 6373- 6380 ,(2005) , 10.3748/WJG.V11.I40.6373
Steven M. Opal, Endotoxins and other sepsis triggers. Contributions To Nephrology. ,vol. 167, pp. 14- 24 ,(2010) , 10.1159/000315915
Peter J Barnes, Glucocorticosteroids: current and future directions British Journal of Pharmacology. ,vol. 163, pp. 29- 43 ,(2011) , 10.1111/J.1476-5381.2010.01199.X
Georg Stary, Irene Klein, Wolfgang Bauer, Frieder Koszik, Bärbel Reininger, Sabine Kohlhofer, Kristina Gruber, Hans Skvara, Thomas Jung, Georg Stingl, Glucocorticosteroids Modify Langerhans Cells To Produce TGF-β and Expand Regulatory T Cells Journal of Immunology. ,vol. 186, pp. 103- 112 ,(2011) , 10.4049/JIMMUNOL.1002485
Larry Kalish, Kornkiat Snidvongs, Rahuram Sivasubramaniam, Daron Cope, Richard J Harvey, Topical steroids for nasal polyps Cochrane Database of Systematic Reviews. ,vol. 12, ,(2016) , 10.1002/14651858.CD006549.PUB2
Jodie M Burton, Paul W O'Connor, Marika Hohol, Joseph Beyene, Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis Cochrane Database of Systematic Reviews. ,vol. 12, ,(2012) , 10.1002/14651858.CD006921.PUB2
Daigo Hashimoto, Andrew Chow, Clara Noizat, Pearline Teo, Mary Beth Beasley, Marylene Leboeuf, Christian D Becker, Peter See, Jeremy Price, Daniel Lucas, Melanie Greter, Arthur Mortha, Scott W Boyer, E Camilla Forsberg, Masato Tanaka, Nico van Rooijen, Adolfo García-Sastre, E Richard Stanley, Florent Ginhoux, Paul S Frenette, Miriam Merad, Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes Immunity. ,vol. 38, pp. 792- 804 ,(2013) , 10.1016/J.IMMUNI.2013.04.004
I. Rogatsky, S. K. Logan, M. J. Garabedian, ANTAGONISM OF GLUCOCORTICOID RECEPTOR TRANSCRIPTIONAL ACTIVATION BY THE C-JUN N-TERMINAL KINASE Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 2050- 2055 ,(1998) , 10.1073/PNAS.95.5.2050